Upgrade to SI Premium - Free Trial

vTv Therapeutics (VTVT) Tops Q1 EPS by 165c

May 13, 2026 4:19 PM

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

Categories

Earnings